We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

The mRNA vaccines for HIV “are not at all dead in the water,” Kublin told me. If needed, scientists could tweak the vaccine recipe, or combine the mRNA approach with another technology.

Photo: belyaaa via 123rf New research employing mRNA technology — which gained prominence during the COVID-19 pandemic — may offer the key to developing a cure for HIV. One of the chief ...

Researchers in Australia have developed a novel lipid nanoparticle, dubbed LNP X, capable of delivering mRNA into white blood cells harboring HIV (pictured here). Corona Borealis – stock.adobe.com ...